Please assess the completion status of the following clinical trial:

Trial Title: Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed non-small cell lung cancer (NSCLC)~  * Must have clinical and/or pathological evidence of pleural spread~ * Primary tumor must be resectable as assessed by the attending thoracic surgeon~* Patients who have received or are currently receiving two-to-four courses of standard front-line chemotherapy are eligible~PATIENT CHARACTERISTICS:~* Must be medically fit to tolerate surgery~* No CTCAE v3.0 grade III-IV elevations in liver transaminases~* Bilirubin ≤ 1.5 mg/dL~* No known HIV infection~* Not pregnant or nursing~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics~* No prior treatment for NSCLC except pleurodesis or standard front-line chemotherapy~* No prior pemetrexed disodium chemotherapy~* No prior mantle radiotherapy~* No concurrent chemotherapy or radiotherapy during the active study treatment period~  * Post-operative radiotherapy will be administered as clinically indicated

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Photodynamic Therapy (Type: EXPERIMENTAL): PDT

Based on this trial design, predict the completion outcome and termination type (if applicable).